Improving access to medications for opioid use disorder
Localize Opioid Use Disorder (LOUD) response to increase medication access
This study is all about finding ways to make it easier for people with opioid use disorder to get the treatment they need by looking at things like community support, insurance, and any stigma they might face, so that we can create better services that really help individuals in different areas.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11049392 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to medications for opioid use disorder (OUD) by identifying and addressing barriers that individuals face in obtaining treatment. It utilizes a patient-centered approach to assess various factors that influence access, such as community characteristics, insurance coverage, and stigma. The study aims to develop a set of measures and tools that can be used to monitor and improve the delivery of opioid treatment services across different communities. By tailoring services to meet the specific needs of patients, the research seeks to ensure that more individuals can receive the help they need.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals struggling with opioid use disorder who may face barriers to accessing treatment.
Not a fit: Patients who are not affected by opioid use disorder or those who already have adequate access to treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of patients who receive effective treatment for opioid use disorder.
How similar studies have performed: Previous research has shown that addressing barriers to treatment access can improve patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Joudrey, Paul J — University of Pittsburgh at Pittsburgh
- Study coordinator: Joudrey, Paul J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.